Tectonic Therapeutic, Inc.
TECX
39 insider filings · Latest: Sep 25, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | Oct 2 9:00 PM | Peter McnamaraChief Scientific Officer | Sale | 536 | $23.04 | $12.3K | 54,305(D) | View → |
| Sep 30, 2026 | Sep 30 8:21 PM | PETER MCNAMARA | Proposed Sale | 493 | $23.34 | $11.5K | — | View → |
| Aug 27, 2026 | Aug 27 9:20 PM | TERRANCE MCGUIRE | Proposed Sale | 7,513 | $36.83 | $276.7K | — | View → |
| Aug 25, 2026 | Aug 26 8:30 PM | Peter McnamaraChief Scientific Officer | Sale | 43 | $36.52 | $1.6K | 55,285(D) | View → |
| Aug 21, 2026 | Aug 21 9:58 PM | TERRANCE MCGUIRE | Proposed Sale | 10,200 | $37.61 | $383.7K | — | View → |
| Aug 12, 2026 | Aug 14 11:25 PM | Peter McnamaraChief Scientific Officer | Sale | 43 | $35.00 | $1.5K | 55,285(D) | View → |
| Aug 12, 2026 | Aug 12 8:37 PM | PETER MCNAMARA | Proposed Sale | 129 | $31.87 | $4.1K | — | View → |
| Jun 30, 2026 | Jul 1 9:19 PM | Peter McnamaraChief Scientific Officer | Sale | 172 | $35.00 | $6.0K | 55,285(D) | View → |
| Jun 30, 2026 | Jun 30 8:38 PM | PETER MCNAMARA | Proposed Sale | 172 | $33.09 | $5.7K | — | View → |
| May 4, 2026 | May 6 9:00 PM | Marcella K. RuddyChief Medical Officer | Sale | 1,065 | $30.00 | $31.9K | 67,682(D) | View → |
| Apr 1, 2026 | Apr 3 8:24 PM | Marcella K. RuddyChief Medical Officer | Sale | 1,000 | $31.05 | $31.1K | 68,747(D) | View → |
| Mar 6, 2026 | Mar 9 10:15 PM | Marcella K. RuddyChief Medical Officer | Sale | 10,000 | $30.00 | $300.0K | 69,747(D) | View → |
| Mar 6, 2026 | Mar 9 10:12 PM | Peter McnamaraChief Scientific Officer | Sale | 6,262 | $30.17 | $188.9K | 55,285(D) | View → |
| Mar 6, 2026 | Mar 6 9:31 PM | PETER MCNAMARA | Proposed Sale | 6,262 | $27.85 | $174.4K | — | View → |
| Mar 6, 2026 | Mar 6 9:31 PM | MARCELLA RUDDY | Proposed Sale | 12,065 | $27.85 | $336.0K | — | View → |
| Mar 4, 2026 | Mar 5 10:45 PM | Peter McnamaraChief Scientific Officer | Sale | 1,650 | $25.00 | $41.3K | 58,832(D) | View → |
| Mar 3, 2026 | Mar 5 10:45 PM | Peter McnamaraChief Scientific Officer | Sale | 1,649 | $22.06 | $36.4K | 37,482(D) | View → |
| Feb 11, 2026 | Mar 5 9:30 PM | Alise ReicinDirector, Chief Executive Officer | Purchase | 2,500 | $21.10 | $52.8K | 127,030(I) | View → |
| Mar 4, 2026 | Mar 4 9:42 PM | PETER MCNAMARA | Proposed Sale | 1,650 | $24.40 | $40.3K | — | View → |
| Mar 3, 2026 | Mar 3 9:44 PM | PETER MCNAMARA | Proposed Sale | 1,649 | $23.00 | $37.9K | — | View → |
Page 1 of 2
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | Sep 8 8:45 PM | Marc SchwabishChief Business Officer | Grant/Award | 17,750 | $29.92 | 17,750(D) | View → |
| Sep 3, 2026 | Sep 8 8:45 PM | Peter McnamaraChief Scientific Officer | Grant/Award | 21,000 | $29.92 | 21,000(D) | View → |
| Sep 3, 2026 | Sep 8 8:45 PM | Daniel LochnerChief Financial Officer | Grant/Award | 24,250 | $29.92 | 24,250(D) | View → |
| Sep 3, 2026 | Sep 8 8:45 PM | Marcella K. RuddyChief Medical Officer | Grant/Award | 24,250 | $29.92 | 24,250(D) | View → |
| Sep 3, 2026 | Sep 8 8:45 PM | Alise ReicinDirector, Chief Executive Officer | Grant/Award | 69,250 | $29.92 | 69,250(D) | View → |
| Aug 25, 2026 | Aug 26 8:30 PM | Peter McnamaraChief Scientific Officer | Option Exercise | 43 | $14.71 | 7,787(D) | View → |
| Aug 12, 2026 | Aug 14 11:25 PM | Peter McnamaraChief Scientific Officer | Option Exercise | 43 | $14.71 | 7,830(D) | View → |
| Jun 30, 2026 | Jul 1 9:19 PM | Peter McnamaraChief Scientific Officer | Option Exercise | 172 | $14.71 | 7,873(D) | View → |
| Jun 11, 2026 | Jun 12 8:30 PM | Daniel LochnerChief Financial Officer | Grant/Award | 7,500 | $16.80 | 7,500(D) | View → |
| Jun 9, 2026 | Jun 10 8:45 PM | SPRINGER TIMOTHY ADirector, 10% Owner | Grant/Award | 10,200 | $28.56 | 10,200(D) | View → |
| Jun 9, 2026 | Jun 10 8:45 PM | Praveen P. TipirneniDirector | Grant/Award | 10,200 | $28.56 | 10,200(D) | View → |
| Jun 9, 2026 | Jun 10 8:45 PM | Phillip B. DonenbergDirector | Grant/Award | 10,200 | $28.56 | 10,200(D) | View → |
| Jun 9, 2026 | Jun 10 8:45 PM | Stefan VitorovicDirector | Grant/Award | 10,200 | $28.56 | 10,200(D) | View → |
| Jun 8, 2026 | Jun 10 8:36 PM | Jessica Caroline ChutterDirector | Grant/Award | 20,400 | $29.10 | 20,400(D) | View → |
| Apr 1, 2026 | Apr 3 8:23 PM | Francois NaderDirector | Grant/Award | 20,400 | $30.78 | 20,400(D) | View → |
| Mar 6, 2026 | Mar 9 10:12 PM | Peter McnamaraChief Scientific Officer | Option Exercise | 2,715 | $14.71 | 8,045(D) | View → |
| Mar 4, 2026 | Mar 5 10:47 PM | Alise ReicinDirector, Chief Executive Officer | Grant/Award | 69,250 | $27.41 | 69,250(D) | View → |
| Mar 4, 2026 | Mar 5 10:46 PM | Marc SchwabishChief Business Officer | Grant/Award | 17,750 | $27.41 | 17,750(D) | View → |
| Mar 4, 2026 | Mar 5 10:45 PM | Peter McnamaraChief Scientific Officer | Grant/Award | 21,000 | $27.41 | 21,000(D) | View → |
| Mar 4, 2026 | Mar 5 10:43 PM | Daniel LochnerChief Financial Officer | Grant/Award | 24,250 | $27.41 | 24,250(D) | View → |
Page 1 of 2
Next →